anesthetic drugs Flashcards
CNS drugs must ….(according to structure_
- be lipid soluble (cross BBB)
or 2. be actively transported
anesthetic drugs - solubility in blood / lipids
low solubility in blood –> rapid induction and recovery times
increased solubility in lipids –> increased potency
inhaled anesthetics - MAC? (definition)
minimal alveolar concentration (of inhaled anesthetic) required to prevent 50% of subjects from moving in response to noxious stimulus (e.g. skin incision)
potency vs minimal alveolar concentration (EQUATION)
potency = 1 / MAC
example of inhaled anesthetic with low blood and lipid solubility
nitrous oxide
example of inhaled anesthetic with increased blood and lipid solubility
halothane
inhaled anesthetic with increased blood and lipid solubility –> …. (potency and induction)
high potency
low induction
inhaled anesthetic with low blood and lipid solubility –> …. (potency and induction)
low potency
high induction
inhaled anesthetics - drugs
(HALOTHANE, -FLURANE, N20)
- halothane 2. enflurane 3. isoflurane
- sevoflurane 5. methoxyflurane
- nitrous oxide (N2O) 7. desflurane
inhaled anesthetics - mechanism of action
unknown
inhaled anesthetics - side effects (and which drug) and other effects
- fulminant hepatic necrosis (halothane)
- nephrotoxicity (methoxyflurane)
- proconvulsant (enflurane)
- expansion of trapped gas in body cavity (N20)
- malignant hyperthermia (all)
- Myocardial and resp depression
- nausea/emesis
- increased cerrebral blood flow (decreased metabolic demands)
malignant hyperthermia - definition/causes/manifestation ….
rare, life threatening condition in which inhaled anesthetics or succinylcholine induce fever and severe muscle contraction
malignant hyperthermia - manifestations / susceptibility
fever and severe muscle contraction
Susceptibility is AD with variable expression –> mutation in voltage-sensitive ryanodine receptor cause increase Ca+ release from sarcoplasmic reticulum
malignant hyperthermia - treatment
dantrolene
Intravenous anesthetics - groups/drugs?
- barbiturates - thiopental
- benzodiazepines - midazolam
- arylcyclohexylamines - ketamine
- opioids - morphine, fentanyl
- propofol
Intravenous anesthetics - thiopental - properties
high potency, high lipid solubility, rapid entry BBB
Intravenous anesthetics - thiopental - clinical uses
induction of anesthesia and and short surgical procedures
Intravenous anesthetics - thiopental’s effect terminated by
rapid redistribution into tissue and fat
Intravenous anesthetics - thiopental - side effects
decreases cerebral flow
Intravenous anesthetics - benzodiazepines - drugs?
midazolam
Intravenous anesthetics - midazolam - clinical uses
- MC drug used for endoscopy
2. adjunctively with gaseous anesthetics and narcotics
Intravenous anesthetics - midazolam - side effects
- severe postoperative respiratory depression
- low BP
- anterograde amnesia
Intravenous anesthetics - treat midazolam overdose with
flumazenil
Intravenous anesthetics - arylcyclohexylamines - drugs
ketamine
Intravenous anesthetics - ketamine - mechanism of action
PCP analog that act as a dissociative anesthetics
Block NMDA receptors
cardiovascular stimulant
Intravenous anesthetics - ketamine - side effects
- hallucination
- bad dreams
- disorientation
Intravenous anesthetics - ketamine - except its action an anesthetic is also a
cardivascular stimulant –> useful for patients in cardiogenic of septic shock
Intravenous anesthetics - ketamine effect on cerebral arteries
increase cerebral blood flow
Intravenous anesthetics - opioids - drugs
- morphine
2. fentanyl